瀏覽人氣：601

黃尚本 醫師

最高學歷：臺北醫學大學臨床醫學研究所醫學博士

研究領域：神經科學、癌症基因體學

分機：

電子信箱：tch39356@tzuchi.com.tw

https://orcid.org/0000-0002-3064-0899

  • 利用基因大數據資料庫，發現新的生物標記來預測癌症病患的預後與治療反應，並探索可能的分子機轉 (Identification of novel biomarkers for prognosis and therapeutic response in cancer patients and exploring the underlying molecular mechanisms)
  • 將大數據資料視覺化與圖像化以利更深入的分析(visualization of big data for further analysis)
  • 癌細胞抗藥機制的研究(identifying the mechanism of drug resistance in cancer cells)
  • 臨床神經醫學：腦中風(stroke)
  • 腎臟科：洪思群醫師、彭清秀醫師、王奕淳醫師等。
  • 心臟科：黃玄禮醫師、周星輝醫師。

  • Li Wei, Yu-Kai Su, Chien-Min Lin, Tsu-Yi Chao, Shang-Pen Huang, Thanh-Tuan Huynh, Hsun-Jin Jan, Jacqueline Whang-Peng, Jeng-Fong Chiou, Alexander T.H. Wu, Michael Hsiao
    Preclinical investigation of ibrutinib, a Bruton’s kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes
    Oncotarget. 2016; 7:69961-69975. https://doi.org/10.18632/oncotarget.11572 (IF: not available, Oncology).

  • Shang-Pen Huang, Pei-Yao Liu, Chih-Jung Kuo, Chi-Long Chen, Wei-Jiunn Lee, Yu-Hui Tsai, Yuan-Feng Lin
    The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer
    Journal of Hematology & Oncology. 2017; 10:114 (IF: 23.168, Hematology: 4/78).

  • Shang-Pen Huang, Yu-Chan Chang, Qie Hua Low, Alexander T.H. Wu, Chi-Long Chen, Yuan-Feng Lin, Michael Hsiao
    BICD1 expression, as a Potential Biomarker for Predicting the Prognosis and Response to Therapy in Glioblastoma patients
    Oncotarget. 2017; 8(69):113766-113791. doi: 10.18632/oncotarget.22667 (IF: not available, Oncology).

  • Shang-Pen Huang, Jean Chiou, Yi-Hua Jan, Tsung-Ching Lai, Yung-Luen Yu, Michael Hsiao, Yuan-Feng Lin

    Over-expression of Lysyl Oxidase is associated with poor prognosis and response to therapy of patients with lower grade gliomas
    Biochemical and Biophysical Research Communication. 2018; 501(3):619-627. (IF: 3.322, Biophysics: 39/72)

  • Yu-Chan Chang, Hsing-Fang Tsai, Shang-Pen Huang, Chi-Long Chen, Michael Hsiao, Wen-Chiuan Tsai
    Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas.
    Cancers (Basel). 2019 Aug 23;11(9). (IF: 6.575, Oncology: 60/245).

  • Shang-Pen Huang, Yung-Chieh Chan, Shang-Yu Huang, Yuan-Feng Lin
    Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion
    Cancers (Basel). 2019 Dec 18;12(1). (IF: 6.575, Oncology: 60/245).